Mutations in PINK1 cause autosomal recessive Parkinson's disease. PINK1 is a mitochondrial
kinase of unknown function. We investigated calcium homeostasis and mitochondrial …

Protein aggregation causes α-synuclein to switch from its physiological role to a pathological
toxic gain of function. Under physiological conditions, monomeric α-synuclein improves …

Biological tissues require oxygen to meet their energetic demands. However, the consumption
of oxygen also results in the generation of free radicals that may have damaging effects …

Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in humans.
Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detected …

To evaluate these risks, we enrolled 200 patient-facing HCWs between March 26 and April 8,
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …

In mice, targeted deletion of the serine protease HtrA2 (also known as Omi) causes
mitochondrial dysfunction leading to a neurodegenerative disorder with parkinsonian features. In …

that emerged in the UK with the second COVID-19 wave in late 2020. The efficacy of currently
licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses 12 …

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause
autosomal dominant Parkinson's disease. Few mutations in this gene have been identified. We …

Mutations in PTEN-induced kinase 1 (PINK1) cause early onset autosomal recessive
Parkinson's disease (PD). PINK1 is a 63 kDa protein kinase, which exerts a neuroprotective …

Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune monitoring
(CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in …